Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


26.02.2024

1 Ann Oncol
2 Ann Surg Oncol
3 Ann Thorac Surg
3 BMC Cancer
1 BMJ
1 Br J Cancer
1 Cancer
1 Cancer Cell
1 Cancer Chemother Pharmacol
1 Cancer Epidemiol Biomarkers Prev
3 Clin Cancer Res
2 Clin Lung Cancer
1 Clin Nucl Med
3 Eur J Cancer
1 Eur J Cardiothorac Surg
1 Hum Pathol
1 Int J Cancer
1 Int J Oncol
2 Int J Radiat Oncol Biol Phys
3 J Cancer Res Clin Oncol
2 Lung Cancer
1 Oncologist
1 PLoS Genet
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Oncol

  1. SANTUCCI C, Mignozzi S, Malvezzi M, Boffetta P, et al
    European cancer mortality predictions for the year 2024 with focus on colorectal cancer.
    Ann Oncol. 2024 Jan 17:S0923-7534(23)05110-4. doi: 10.1016/j.annonc.2023.
    PubMed         Abstract available


    Ann Surg Oncol

  2. LIN JP, Liu SY, Wang F
    ASO Author Reflections: Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery-A National Real-World Cohort Study.
    Ann Surg Oncol. 2024 Feb 23. doi: 10.1245/s10434-024-15062.
    PubMed        

  3. PARK S, Choe J, Lee SM, Choi S, et al
    Surgical Outcomes in Non-Small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
    Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-14984.
    PubMed         Abstract available


    Ann Thorac Surg

  4. STILES BM, Rodriguez-Quintero JH
    A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
    Ann Thorac Surg. 2024;117:593.
    PubMed        

  5. ALDERETE IS, Nakata K, Hartwig MG
    Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
    PubMed        

  6. PONTULA A, Spies CS, Hartwig MG
    Incidentally Found Lung Cancer Following Lung Transplantation: Apples and Oranges.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
    PubMed        


    BMC Cancer

  7. CHENG WC, Lin CC, Liao WC, Lin YC, et al
    The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study.
    BMC Cancer. 2024;24:228.
    PubMed         Abstract available

  8. LANG Y, Lin Y, Deng M, Liu X, et al
    Economic evaluation of cemiplimab plus chemotherapy regimen for advanced non-small-cell lung cancer.
    BMC Cancer. 2024;24:236.
    PubMed         Abstract available

  9. CHEN HC, Kuo CY, Chang Y, Tsai DL, et al
    5-Methoxytryptophan enhances the sensitivity of sorafenib on the inhibition of proliferation and metastasis for lung cancer cells.
    BMC Cancer. 2024;24:248.
    PubMed         Abstract available


    BMJ

  10. HOPKINSON NS
    Smoking and lung cancer-70 long years on.
    BMJ. 2024;384:q443.
    PubMed        


    Br J Cancer

  11. BLECHTER B, Wong JYY, Chien LH, Shiraishi K, et al
    Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity.
    Br J Cancer. 2024 Feb 22. doi: 10.1038/s41416-024-02592.
    PubMed         Abstract available


    Cancer

  12. WEST HJ, Pennell NA
    Lessons from ADAURA: Can we improve on a positive trial?
    Cancer. 2024;130:659-664.
    PubMed        


    Cancer Cell

  13. NABET BY, Hamidi H, Lee MC, Banchereau R, et al
    Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
    Cancer Cell. 2024 Feb 9:S1535-6108(24)00015-1. doi: 10.1016/j.ccell.2024.
    PubMed         Abstract available


    Cancer Chemother Pharmacol

  14. MA X, Sun Z, Chen H, Cao L, et al
    18beta-glycyrrhetinic acid suppresses Lewis lung cancer growth through protecting immune cells from ferroptosis.
    Cancer Chemother Pharmacol. 2024 Feb 21. doi: 10.1007/s00280-024-04639.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  15. BOOKSTEIN A, Po J, Tseng C, Larson TV, et al
    Association between Airport Ultrafine Particles and Lung Cancer Risk: The Multiethnic Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available


    Clin Cancer Res

  16. WEI D, Wang L, Zuo X, Maitra A, et al
    A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer.
    Clin Cancer Res. 2024;30:655-662.
    PubMed         Abstract available

  17. KASI PM, Lee JK, Pasquina LW, Decker B, et al
    Circulating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
    Clin Cancer Res. 2024;30:836-848.
    PubMed         Abstract available

  18. ZHOU I, Plana D, Palmer AC
    Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial.
    Clin Cancer Res. 2024;30:786-792.
    PubMed         Abstract available


    Clin Lung Cancer

  19. MATSUBARA T, Yamaguchi M, Shimokawa M, Okamoto I, et al
    Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial.
    Clin Lung Cancer. 2024 Jan 28:S1525-7304(24)00010.
    PubMed         Abstract available

  20. PILON Y, Rokah M, Seitlinger J, Sepesi B, et al
    Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
    Clin Lung Cancer. 2023 Dec 19:S1525-7304(23)00264.
    PubMed         Abstract available


    Clin Nucl Med

  21. SINGH A, Shah HJ, Dabiri BE, Landman W, et al
    Renal Collision Tumor: A Case of Small Cell Lung Cancer Metastasis to Renal Angiomyolipoma.
    Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005136.
    PubMed         Abstract available


    Eur J Cancer

  22. GOMEZ-RANDULFE I, Leporati R, Gupta B, Liu S, et al
    Recent advances and future strategies in first-line treatment of ES-SCLC.
    Eur J Cancer. 2024;200:113581.
    PubMed         Abstract available

  23. WANG M, Wang T, Shan J, Sun Y, et al
    Alectinib induced vitiligo with rapid re-pigmentation.
    Eur J Cancer. 2024;200:113582.
    PubMed        

  24. STRATMANN JA, Althoff FC, Doebel P, Rauh J, et al
    Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.
    Eur J Cancer. 2024;201:113911.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  25. SOLDATH P, Binderup T, Kjaer A, Knigge U, et al
    Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms.
    Eur J Cardiothorac Surg. 2024;65:ezae030.
    PubMed         Abstract available


    Hum Pathol

  26. IVANOVA M, Frascarelli C, Cerbelli B, Pignataro MG, et al
    PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
    Hum Pathol. 2024;144:22-27.
    PubMed         Abstract available


    Int J Cancer

  27. YIN X, Kishida R, Abe SK, Islam MR, et al
    Association between reproductive factors with lung cancer incidence and mortality: A pooled analysis of over 308,000 females in the Asia cohort consortium.
    Int J Cancer. 2024 Feb 20. doi: 10.1002/ijc.34866.
    PubMed         Abstract available


    Int J Oncol

  28. XIE L, Xie D, Du Z, Xue S, et al
    A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
    Int J Oncol. 2024;64:38.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  29. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
    A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
    PubMed         Abstract available

  30. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
    A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  31. KRIZOVA L, Benesova I, Zemanova P, Spacek J, et al
    Immunophenotyping of peripheral blood in NSCLC patients discriminates responders to immune checkpoint inhibitors.
    J Cancer Res Clin Oncol. 2024;150:99.
    PubMed         Abstract available

  32. WANG Y, Dong A, Jin M, Li S, et al
    TEP RNA: a new frontier for early diagnosis of NSCLC.
    J Cancer Res Clin Oncol. 2024;150:97.
    PubMed         Abstract available

  33. NIU L, Wu H, Gao R, Chen L, et al
    Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT.
    J Cancer Res Clin Oncol. 2024;150:94.
    PubMed         Abstract available


    Lung Cancer

  34. LAESEKE P, Ng C, Naghi A, Wright GWJ, et al
    Response to letter: Microwave ablation for Early-Stage Non-Small cell Lung Cancer: Don't Put the Cart before the stereotactic Horse.
    Lung Cancer. 2024;189:107504.
    PubMed        

  35. SAAL J, Bald T, Eckstein M, Ralser DJ, et al
    Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition.
    Lung Cancer. 2024;189:107505.
    PubMed         Abstract available


    Oncologist

  36. BRIA E, Morgillo F, Garassino MC, Ciardiello F, et al
    Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
    Oncologist. 2024 Feb 20:oyad342. doi: 10.1093.
    PubMed         Abstract available


    PLoS Genet

  37. KHOUJA JN, Sanderson E, Wootton RE, Taylor AE, et al
    Estimating the health impact of nicotine exposure by dissecting the effects of nicotine versus non-nicotine constituents of tobacco smoke: A multivariable Mendelian randomisation study.
    PLoS Genet. 2024;20:e1011157.
    PubMed         Abstract available


    PLoS One

  38. CHEN Q, Li W, Cai N, Chen W, et al
    Comparison of postoperative complications in mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0298368.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  39. JANSEN RA, Mainardi S, Dias MH, Bosma A, et al
    Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in KRAS-mutant cancers.
    Proc Natl Acad Sci U S A. 2024;121:e2319492121.
    PubMed         Abstract available


    Science

  40. KRISHNA C, Tervi A, Saffern M, Wilson EA, et al
    An immunogenetic basis for lung cancer risk.
    Science. 2024;383:eadi3808.
    PubMed         Abstract available


    Thorax

  41. KOO MM, Mounce LTA, Rafiq M, Callister MEJ, et al
    Guideline concordance for timely chest imaging after new presentations of dyspnoea or haemoptysis in primary care: a retrospective cohort study.
    Thorax. 2024;79:236-244.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.